Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Glargine vs NPH in Type 1 Diabetes Skipping Breakfast
NCT00313937Phase 4Completed
- Sponsor
- Sanofi
- Start
- Nov 2001
- Primary completion
- Jun 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine in type 1 diabetes mellitus (T1D), sponsored by Sanofi. Started Nov 2001; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00313937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00313937.